US Stock MarketDetailed Quotes

MRUS Merus

Watchlist
  • 56.550
  • -1.100-1.91%
Close Jun 14 16:00 ET
  • 56.600
  • +0.050+0.09%
Post 19:08 ET
3.75BMarket Cap-20714P/E (TTM)

About Merus Company

Merus NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of bispecific antibody therapeutics. Its pipeline includes Biclonics for solid and hematological tumors. The company was founded by Ton Logtenberg and Hennie Hoogenboom on June 16, 2003 and is headquartered in Utrecht, the Netherlands.

Company Profile

SymbolMRUS
Company NameMerus
Listing DateMay 19, 2016
Issue Price10.00
Founded2003
CEODr. Sven Ante Lundberg, M.D.
MarketNASDAQ
Employees229
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
AddressUppsalalaan 17,3rd-4th Floor
CityUtrecht
ProvinceUtrecht
CountryNetherlands (the)
Zip Code3584 CM
Phone31-30-253-88-00
Websitehttp://www.merus.nl

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Sven Ante Lundberg, M.D.
  • Director, President and Chief Executive Officer
  • 4.67M
  • Gregory D. Perry
  • Chief Financial Officer
  • 6.21M
  • Harry Shuman
  • Chief Accounting Officer
  • --
  • Peter B. Silverman, J.D.
  • Chief Operating Officer and General Counsel
  • 1.95M
  • Andrew Joe
  • Chief Medical Officer
  • 1.66M
  • Dr. Hui Liu, M.B.A.,PhD
  • Chief Business Officer and Head of Merus U.S.
  • 1.69M
  • Dr. Anand Mehra, M.D.
  • Chairman of the Board
  • 417.56K
  • Mark T. Iwicki
  • Independent Director
  • 311.06K
  • Dr. Victor Sandor, C.M.,M.D.
  • Independent Director
  • 303.56K
  • Dr. Maxine Gowen,PhD
  • Independent Director
  • 305.06K
  • Paolo Pucci
  • Independent Director
  • 309.56K
  • Len Kanavy
  • Independent Director
  • 303.56K
  • Jason Haddock
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg